Overweight/Obesity Clinical Trial
— LÄTTAOfficial title:
Interventions for Lifestyle Changes to Promote Weight Reduction, a Randomized Controlled Trial in Primary Health Care
Verified date | May 2012 |
Source | Örebro County Council |
Contact | n/a |
Is FDA regulated | No |
Health authority | Sweden: Regional Ethical Review Board |
Study type | Interventional |
The purpose of this study is to examine the effects of a weight reduction program in adults, seen in a primary care setting, with overweight/obesity perceived as a health problem or with diseases related to overweight/obesity and ambitions to achieve weight reduction as part of treatment.
Status | Completed |
Enrollment | 133 |
Est. completion date | October 2011 |
Est. primary completion date | June 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Adult patients between 18 and 70 years of age who consulted or were in care for overweight/obesity with or without type 2 diabetes - Hypertension, CVD - Coronary heart disease (CHD) - Dyslipidemia - Gallstone or musculoskeletal disorders Exclusion Criteria: - Patients were not eligible if they were already taking part in another weight control program - Understood the Swedish language poorly - Were mentally ill or had an alcohol or drug addiction. - Nor were they eligible if they had a physical disability preventing intensified physical activity or were pregnant at study start. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Sweden | Orebro County Council | Orebro |
Lead Sponsor | Collaborator |
---|---|
Örebro County Council |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of patients who achieved target weight at two years | 2 years | No | |
Secondary | Clinical or laboratory manifestations of their baseline illness (type 2 diabetes, hypertension, CHD, dyslipidemia) or death of any cause. | 5 years | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01404416 -
Effect of Antenatal Iron-contained Multiple Micronutrient Supplementation, Cesarean Delivery, and CDMR on Child Health
|
N/A | |
Completed |
NCT04773977 -
Clinical Study of IBI362 in Healthy Chinese Male Subjects
|
Phase 1 | |
Recruiting |
NCT06147752 -
Mobile Internet Healthcare and Three Disciplines Co-management Intervention for Overweight/Obese Prediabetic Patients
|
N/A | |
Active, not recruiting |
NCT03573856 -
Reducing Diabetes Risk Factors in American Indian Children: Tribal Turning Point
|
N/A | |
Recruiting |
NCT03851627 -
Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism
|
Phase 4 | |
Completed |
NCT03032731 -
Trial of a New Online Programme for Physical Activity and Healthy Eating.
|
N/A | |
Active, not recruiting |
NCT01349166 -
Effects of 3 Months of Supervised Exercise Training
|
N/A | |
Completed |
NCT05009615 -
Efficacy of Hydroxycinnamates and Beta-glucans as a Dietary Tool Against Obesity (OBHEALTH)
|
N/A |